Integra LifeSciences Holdings Corporation (IART)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:49PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.64B |
| Enterprise value | 4.91B |
| Trailing P/E | 22.13 |
| Forward P/E | 12.18 |
| PEG ratio (5-yr expected) | 1.01 |
| Price/sales (ttm) | 2.36 |
| Price/book (mrq) | 2.19 |
| Enterprise value/revenue | 3.13 |
| Enterprise value/EBITDA | 13.56 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.12 |
| 52-week change 3 | -36.90% |
| S&P500 52-week change 3 | -13.66% |
| 52-week high 3 | 74.98 |
| 52-week low 3 | 41.87 |
| 50-day moving average 3 | 51.05 |
| 200-day moving average 3 | 59.66 |
Share statistics
| Avg vol (3-month) 3 | 485.11k |
| Avg vol (10-day) 3 | 531.49k |
| Shares outstanding 5 | 83.5M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 72.49M |
| % held by insiders 1 | 13.01% |
| % held by institutions 1 | 90.56% |
| Shares short (30 Aug 2022) 4 | 3.95M |
| Short ratio (30 Aug 2022) 4 | 9.21 |
| Short % of float (30 Aug 2022) 4 | 6.30% |
| Short % of shares outstanding (30 Aug 2022) 4 | 4.73% |
| Shares short (prior month 28 July 2022) 4 | 4.25M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 2:1 |
| Last split date 3 | 03 Jan 2017 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 June 2022 |
Profitability
| Profit margin | 10.61% |
| Operating margin (ttm) | 18.13% |
Management effectiveness
| Return on assets (ttm) | 4.76% |
| Return on equity (ttm) | 10.28% |
Income statement
| Revenue (ttm) | 1.57B |
| Revenue per share (ttm) | 18.63 |
| Quarterly revenue growth (yoy) | 2.00% |
| Gross profit (ttm) | 976.97M |
| EBITDA | 404.32M |
| Net income avi to common (ttm) | 166.3M |
| Diluted EPS (ttm) | 1.98 |
| Quarterly earnings growth (yoy) | 27.70% |
Balance sheet
| Total cash (mrq) | 451.52M |
| Total cash per share (mrq) | 5.41 |
| Total debt (mrq) | 1.72B |
| Total debt/equity (mrq) | 103.41 |
| Current ratio (mrq) | 3.85 |
| Book value per share (mrq) | 19.89 |
Cash flow statement
| Operating cash flow (ttm) | 262.88M |
| Levered free cash flow (ttm) | 185.93M |
© 2022 Yahoo. All rights reserved.
